Primary CNS Melanocytic Tumors — Trials

Primary CNS Melanocytic Tumors — Trials · CancerIndex

Clinical trials

Registered studies

7 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Children's Oncology Group
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07411144	Gemcitabine as Maintenance Treatment for Diffuse Pleural Mesothelioma(GEMO)	completed	Phase 2	64	National Cancer Institute, EgyptOTHER	1	Feb 13, 2026	clinicaltrials
NCT00492089	Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer	completed	Phase 2	11	National Cancer Institute (NCI)NIH	1	May 9, 2014